The charges that surprise people are separate consultation fees, lab work billed locally, cold-chain shipping surcharges, membership fees stacked on top of medication, price increases at higher strengths, prepaid bundles that do not refund, and restart fees after a lapse. Where you live affects several of them, mostly through visit rules, lab pricing, and coverage.
The advertised number is a starting-dose number
Almost every quoted monthly figure in this market describes the lowest strength, often during a promotional period. GLP-1 regimens escalate over months by design, so the strength you pay for in month one is rarely the strength you pay for in month eight. Programs handle this in two ways: a flat price at every strength, or a price that rises at each tier. Two programs advertising similar entry rates can finish the year hundreds of dollars apart on that difference alone.
The second layer is the membership. Some services charge a monthly platform or program fee that sits on top of the medication cost and continues whether or not a shipment goes out that month. It appears in the terms rather than the headline, and it compounds over a year.
Fees that move with geography
State rules do not set prices, but they do change what you are required to buy. If your state’s requirements mean a live video consultation rather than an asynchronous questionnaire review, that visit may carry its own fee or a higher one. Your state medical board’s telemedicine guidance is the place to establish what applies, and the service’s terms are the place to see what it charges for each format.
Laboratory work is the second geographic variable. When a program does not run labs in house, an order goes to a draw site near you and the bill follows local pricing, which varies far more than most people expect. Shipping is the third. Temperature-controlled shipments to remote addresses can carry surcharges, and expedited reshipment after a heat excursion may or may not be free depending on the policy.
Where the money actually goes
| Charge | How it usually appears | How to surface it before paying |
|---|---|---|
| Consultation or visit fee | Separate from medication, sometimes per follow-up | Ask what each visit type costs and how often visits are required |
| Membership or program fee | Recurring monthly charge independent of shipments | Read the billing terms, not the pricing page headline |
| Dose-tier increase | Price rises as strength rises | Request the posted price at every strength offered |
| Laboratory testing | Bundled, or ordered out to a local site billed to you | Ask who orders labs, who bills them, and how often |
| Shipping and cold chain | Included, flat, or surcharged by destination | Confirm the shipping line item for your own address |
| Prepaid bundle | Discounted multi-month plan, often nonrefundable | Read the refund terms for stopping mid-plan |
| Restart or reactivation fee | Charged after a gap in treatment | Ask what happens if you pause for a month |
Prepay discounts and the exit cost
Multi-month prepayment is the most common discount structure in cash-pay weight care, and it is also where the largest unrecoverable amounts sit. Side effects during dose escalation cause a meaningful number of people to stop or change course in the first quarter, and a nonrefundable six-month plan turns that clinical decision into a financial one. The question to ask is not whether a refund is offered but what specifically happens to the unused months, in writing.
Cancellation notice periods are the quieter version of the same issue. A service that requires notice before the next billing date can charge one more cycle after you decide to leave. That is ordinary subscription practice rather than a trap, but it belongs in the annual figure.
Building the twelve-month number
The only figure that compares cleanly across services is twelve months of continuous treatment at the strength you would realistically reach. Take that price, add every recurring fee, add labs if they are billed separately, add shipping if it is not included, then multiply. Doing this for three or four services usually reorders the shortlist.
Published pricing is what makes the arithmetic possible, and services differ in how much they post. One state-by-state comparison is maintained by FormBlends, a physician-supervised GLP-1 provider, and similar pages exist from Ro, Hims and Hers, Henry Meds, and Mochi Health. Pages published by companies that appear on them are still useful for the fee categories they name, provided each number is checked on the order page. The manufacturer channels are the cleanest comparison point, since LillyDirect and NovoCare publish per-fill self-pay pricing for Zepbound and Wegovy with no membership layer.
Coverage is a state decision, and it changes the math
Cash pricing only matters if cash is the route. Commercial plans differ on anti-obesity medication and usually require prior authorization. Medicaid coverage of these drugs is decided at state level and varies considerably between programs, so the state agency is the only source that answers for your household. Medicare drug coverage has historically excluded agents used solely for weight loss, with CMS material on Part D setting out the framework. One call before enrolling in a cash program can change the entire calculation.
Approval status is not a fee, but it is part of the price
Compounded semaglutide and compounded tirzepatide are not FDA-approved. FDA has not reviewed those preparations for safety, effectiveness, or manufacturing quality, and it has published concerns about unapproved GLP-1 products marketed for weight loss. The gap between a compounded program and a manufacturer channel is therefore not a straight discount on the same item. Part of it reflects a difference in what has been reviewed, which is worth naming when the two sit in adjacent columns of a spreadsheet.
That review gap is part of why the two categories should never share a column in your total. Services such as Ro, Hims and Hers, Henry Meds, and HealthRX build their offers around compounded GLP-1 medications, while LillyDirect and NovoCare dispense the FDA-approved versions at their own posted self-pay rates. Keeping those two groups on separate lines is what stops a twelve-month estimate from comparing prices that were never for the same thing.
Frequently asked questions
Which fee catches the most people out?
The dose-tier increase. Someone budgets from a starting-strength price, escalates over three or four months as intended, and finds the monthly charge has climbed well past the figure they planned around. Asking for the price at every strength before enrolling removes the surprise entirely.
Do any of these fees differ because of my state’s laws?
Indirectly. State rules can determine whether a live visit is required, and visit format can carry a different fee. Local lab pricing and shipping distance also vary geographically. The medication price itself is set nationally by the service and does not change because of where you live.
Is a program with no membership fee cheaper?
Not necessarily. Services without a membership sometimes price the medication higher, and the combined annual total is what decides it. Compare the full twelve-month figure rather than the structure. A membership that includes labs and unlimited follow-ups can be the better arrangement.
What happens to a prepaid plan if I stop for medical reasons?
It depends on the terms, and they vary widely. Some services prorate, some issue credit toward future treatment, and some refund nothing. Because stopping during escalation is common, this clause deserves more attention than its position in the fine print suggests.
Are shipping costs ever significant?
They can be when temperature control and expedited delivery are involved, particularly for addresses far from the dispensing pharmacy. The larger cost is a shipment that arrives compromised. Ask whether replacement is automatic and free, since that policy is worth more than a few dollars of postage either way.
